Study

Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up. – Cost Effective Supplements

Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/22277556


Conclusion of this study

Optimizing riboflavin status offers a low-cost targeted strategy for managing elevated BP in this genetically at-risk group. These findings, if confirmed in the general population, could have important implications for the prevention of hypertension.


Supplements analyzed in this study

Vitamin B2

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Heart health


Slightly Positive
Vitamin B2


Body systems related to this study


Cardiovascular System
Scroll to top